Study title: Multicenter, double-blind, randomized parallel group study on efficacy of 0.035 mg ethinylestradiol / 2 mg cyproterone acetate and of 0.035 mg ethinylestradiol / 2 mg cyproterone acetate in combination with 10 mg cyproterone acetate in comparison to triphasic ethinylestradiol / norgestimate over 6 cycles in women with acne papulopustulosa
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Skin and Connective Tissue Diseases [C17] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CYPROTERONE + ETHINYLESTRADIOL | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: 307760 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |